A breakthrough in the fight against aggressive tumors

Researchers at the University of Geneva and HUG have developed an innovative technique to combat glioblastoma, a highly aggressive brain tumor. By genetically modifying T lymphocytes to target cancer cells without affecting healthy cells, this approach has shown promising results on rodents. Human clinical trials are the next step. This breakthrough positions Geneva among the leaders in immunotherapy research,